BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34707394)

  • 21. Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer.
    Yang K; Li C; Liu Y; Gu X; Jiang L; Shi L
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TMED2/emp24 is required in both the chorion and the allantois for placental labyrinth layer development.
    Hou W; Jerome-Majewska LA
    Dev Biol; 2018 Dec; 444(1):20-32. PubMed ID: 30236446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic Analysis of the Oncogenic Role of WDR62 in Human Tumors.
    Bu Y; Zhang L; Ma X; Wang R; Zhang X; Li J
    Dis Markers; 2021; 2021():9940274. PubMed ID: 34306258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and Importance of TMED2 in Multiple Myeloma Cells.
    Ge X; Jiang W; Jiang Y; Lv X; Liu X; Wang X
    Cancer Manag Res; 2020; 12():12895-12903. PubMed ID: 33364837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensinogen, a promising gene signature for rectum and stomach adenocarcinoma patients.
    Hu W; Abdel-Maksoud MA; Khalid SY; Malik A; Alkholief M; Mubarak A; Aufy M
    Am J Transl Res; 2022; 14(12):8879-8892. PubMed ID: 36628228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of
    Zheng R; Zhu HL; Hu BR; Ruan XJ; Cai HJ
    World J Clin Cases; 2020 Jul; 8(14):2917-2929. PubMed ID: 32775374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TMED2/p24β1 is expressed in all gestational stages of human placentas and in choriocarcinoma cell lines.
    Zakariyah A; Hou W; Slim R; Jerome-Majewska L
    Placenta; 2012 Mar; 33(3):214-9. PubMed ID: 22212250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2.
    Hou W; Gupta S; Beauchamp MC; Yuan L; Jerome-Majewska LA
    PLoS One; 2017; 12(8):e0182995. PubMed ID: 28797121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Analysis of the Value of SMYD Family Members in the Prognosis and Immune Infiltration of Malignant Digestive System Tumors.
    Liu D; Wang X; Shi E; Wang L; Nie M; Li L; Jiang Q; Kong P; Shi S; Wang C; Yan S; Qin Z; Zhao S
    Front Genet; 2021; 12():699910. PubMed ID: 34335697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A detailed multi-omics analysis of GNB2 gene in human cancers.
    Zhang L; Sahar AM; Li C; Chaudhary A; Yousaf I; Saeedah MA; Mubarak A; Haris M; Nawaz M; Reem MA; Ramadan FA; Mostafa AAM; Feng W; Hameed Y
    Braz J Biol; 2022; 84():e260169. PubMed ID: 35730811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pan-cancer analysis identifies ESM1 as a novel oncogene for esophageal cancer.
    Cui Y; Guo W; Li Y; Shi J; Ma S; Guan F
    Esophagus; 2021 Apr; 18(2):326-338. PubMed ID: 33175267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Oncogene Function of GOLPH3 and Correlated Regulatory Network in Lung Adenocarcinoma.
    Zhang T; Wang Y; Chen Y; Jin S; Gao Y; Zhang D; Wu Y
    Front Oncol; 2021; 11():669684. PubMed ID: 34497755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.
    Chen M; Li S; Liang Y; Zhang Y; Luo D; Wang W
    Front Oncol; 2021; 11():656509. PubMed ID: 34178642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma.
    Yang B; Ji LL; Xu HL; Li XP; Zhou HG; Xiao T; Li XH; Gao ZY; Li JZ; Zhang WD; Wang GS; Li MJ
    J Inflamm Res; 2021; 14():2389-2401. PubMed ID: 34163207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.
    Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C
    Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
    Zou X; Mo Z
    Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets.
    Liu F; Wu H
    J Inflamm Res; 2021; 14():267-285. PubMed ID: 33574689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of ABCC5 Among ATP-Binding Cassette Transporter Family as a New Biomarker for Hepatocellular Carcinoma Based on Bioinformatics Analysis.
    Qiu Y; Li H; Xie J; Qiao X; Wu J
    Int J Gen Med; 2021; 14():7235-7246. PubMed ID: 34737618
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX
    Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pan-Cancer Analysis Based on
    Zhang Y; Wang S; Han S; Feng Y
    Front Oncol; 2022; 12():844794. PubMed ID: 35359375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.